Research & Development

01 May 2020
- Drug Discovery
- Research & Development
Moderna and Lonza announce worldwide strategic collaboration to manufacture Moderna’s vaccine against novel coronavirus

By PBR Staff Writer

Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional Moderna products in the future.
01 May 2020
Drug Discovery
Research & Development
Clinical Trials
Default Table Multi-Parameter Transmitter M800

By victoria.smith

The M800 multi-parameter transmitter provides simultaneous monitoring of one, two or four in-line sensors. It offers measurement of pH/ORP, optical DO, amperometric oxygen (DO as well as O2 gas), conductivity, resistivity, TOC, dissolved ozone, flow and turbidity in pure water as well as process applications.
29 Apr 2020
Drug Discovery
Research & Development
Quotient Sciences and CytoAgents accelerate potential treatment for COVID-19 cytokine storm

By PBR Staff Writer

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc., a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases.
28 Apr 2020
Drug Discovery
Research & Development
Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers

By PBR Staff Writer

Merck, known as MSD outside the United States and Canada, and the Institute for Systems Biology (ISB), announced a new research collaboration to investigate and define the molecular mechanisms of SARS-CoV-2 infection and COVID-19 and identify targets for medicines and vaccines.
28 Apr 2020
Drug Discovery
Research & Development
Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies

By PBR Staff Writer

Affinia Therapeutics has signed a research collaboration deal worth more than $1.6bn with Vertex Pharmaceuticals to discover and develop adeno-associated virus capsids (AAV capsids) to be used in the latter's genetic therapies aimed at treating people with serious diseases.
24 Apr 2020
Drug Discovery
Research & Development
Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies

By PBR Staff Writer

Affinivax, a clinical stage biotechnology company with its novel MAPS technology platform for vaccines and immunotherapies, today announced the completion of a $120 million Series B financing round, led by Viking Global Investors with participation from Bain Capital Life Sciences and Ziff Capital Partners.
24 Apr 2020
Drug Discovery
Research & Development
Agastiya Biotech proceeding with drug candidate for COVID-19

By PBR Staff Writer

Agastiya Biotech announces it has discovered its previously tested anti-cancer small molecule AB001 as a viable SARS-CoV-2 virus therapeutic.
22 Apr 2020
Drug Discovery
Research & Development
Gilead, oNKo-innate to develop NK cells-focused cancer immunotherapies

By PBR Staff Writer

Gilead Sciences and its subsidiary Kite have joined forces with oNKo-innate to discover and develop cancer immunotherapies focused on natural killer (NK) cells.
20 Apr 2020
Drug Discovery
Research & Development
Revive Therapeutics partners with Complete Phytochemical Solutions to advance research initiatives for psilocybin-based pharmaceutical products

By PBR Staff Writer

Revive Therapeutics has engaged Complete Phytochemical Solutions, which specialises in unique and complex analyses and formulation development of phytochemicals, to advance the Company’s research and development initiatives of psilocybin-based products for the pharmaceutical market.
17 Apr 2020
Drug Discovery
Research & Development
Clinical Trials
5000i – Faster Scale-up of Fermentation Processes

By victoria.smith

The Kluyver Center for Genomics of Industrial Fermentation in Delft, Holland, is a consortium of several different Universities and Research Centres.

Drug Discovery

Research & Development

SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody

Atara receives FDA complete response letter for Ebvallo BLA application

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Research & Development

Moderna and Lonza announce worldwide strategic collaboration to manufacture Moderna’s vaccine against novel coronavirus

Default Table Multi-Parameter Transmitter M800

Quotient Sciences and CytoAgents accelerate potential treatment for COVID-19 cytokine storm

Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers

Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies

Affinivax announces $120m Series B financing to advance pipeline of novel MAPS vaccines and immunotherapies

Agastiya Biotech proceeding with drug candidate for COVID-19

Gilead, oNKo-innate to develop NK cells-focused cancer immunotherapies

Revive Therapeutics partners with Complete Phytochemical Solutions to advance research initiatives for psilocybin-based pharmaceutical products

5000i – Faster Scale-up of Fermentation Processes

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found